The Consortium for the Standardization of Influenza Seroepidemiology (CONSISE): a Global Partnership to Standardize Influenza Seroepidemiology and Develop Influenza Investigation Protocols to Inform Public Health Policy

Overview

Journal Influenza Other Respir Viruses

Publisher Wiley

Specialty Microbiology

Date 2013 Jan 3

PMID 23280042

Citations 26

Authors

Maria D Van Kerkhove

Eeva Broberg

Othmar G Engelhardt

John Wood

Angus Nicoll

Affiliations

Soon will be listed here.

Abstract

CONSISE - The consortium for the Standardization of Influenza Seroepidemiology - is a global partnership to develop influenza investigation protocols and standardize seroepidemiology to inform health policy. This international partnership was formed in 2011 and was created out of a need, identified during the 2009 H1N1 pandemic, for timely seroepidemiological data to better estimate pandemic virus infection severity and attack rates to inform policy decisions. CONSISE has developed into a consortium of two interactive working groups: epidemiology and laboratory, with a steering committee composed of individuals from several organizations. CONSISE has had two international meetings with more planned for 2013. We seek additional members from public health agencies, academic institutions and other interested parties.

Citing Articles

Evaluation of Vaccine Immunogenicity-Correlates to Real-World Protection: Influenza.

Laszlofy C, Fazekas G, Barath Z, Vajo Z Viruses. 2024; 16(3).

PMID: 38543806 PMC: 10975834. DOI: 10.3390/v16030441.

Transmission of SARS-CoV-2 in standardised first few X cases and household transmission investigations: A systematic review and meta-analysis.

Lewis H, Marcato A, Meagher N, Valenciano M, Villanueva-Cabezas J, Spirkoska V Influenza Other Respir Viruses. 2023; 16(5):803-819.

PMID: 36825117 PMC: 9343340. DOI: 10.1111/irv.13002.

The ongoing value of first few X studies for COVID-19 in the Western Pacific Region.

Marcato A, Fielding J, Crooks K, Massey P, Le L, Bergeri I Western Pac Surveill Response J. 2022; 13(1):1-3.

PMID: 35402064 PMC: 8989625. DOI: 10.5365/wpsar.2022.13.1.873.

Interlaboratory Reproducibility of Standardized Hemagglutination Inhibition Assays.

Bibby D, Savanovic M, Zhang J, Torelli A, Jeeninga R, Gagnon L mSphere. 2022; 7(1):e0095321.

PMID: 35196123 PMC: 8865924. DOI: 10.1128/msphere.00953-21.

Avian influenza overview September - November 2017.

Brown I, Kuiken T, Mulatti P, Smietanka K, Staubach C, Stroud D EFSA J. 2020; 15(12):e05141.

PMID: 32625395 PMC: 7010192. DOI: 10.2903/j.efsa.2017.5141.

References

Van Kerkhove M, Broberg E, Engelhardt O, Wood J, Nicoll A . The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy. Influenza Other Respir Viruses. 2013; 7(3):231-4. PMC: 5779825. DOI: 10.1111/irv.12068. View

Broberg E, Nicoll A, Amato-Gauci A . Seroprevalence to influenza A(H1N1) 2009 virus--where are we?. Clin Vaccine Immunol. 2011; 18(8):1205-12. PMC: 3147351. DOI: 10.1128/CVI.05072-11. View

. Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec. 2010; 85(24):229-35. View

Van Kerkhove M, Hirve S, Koukounari A, Mounts A . Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries. Influenza Other Respir Viruses. 2013; 7(5):872-86. PMC: 5781221. DOI: 10.1111/irv.12074. View

Lambre C, Terzidis H, Greffard A, Webster R . Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates. J Immunol Methods. 1990; 135(1-2):49-57. DOI: 10.1016/0022-1759(90)90255-t. View

Nicoll A, Ammon A, Amato Gauci A, Amato A, Ciancio B, Zucs P . Experience and lessons from surveillance and studies of the 2009 pandemic in Europe. Public Health. 2010; 124(1):14-23. DOI: 10.1016/j.puhe.2009.12.001. View

Laurie K, Huston P, Riley S, Katz J, Willison D, Tam J . Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting. Influenza Other Respir Viruses. 2012; 7(2):211-24. PMC: 5855149. DOI: 10.1111/j.1750-2659.2012.0370a.x. View

Van Kerkhove M, Asikainen T, Becker N, Bjorge S, Desenclos J, Dos Santos T . Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med. 2010; 7(6):e1000275. PMC: 2879409. DOI: 10.1371/journal.pmed.1000275. View

Lessler J, Cummings D, Read J, Wang S, Zhu H, Smith G . Location-specific patterns of exposure to recent pre-pandemic strains of influenza A in southern China. Nat Commun. 2011; 2:423. PMC: 3757505. DOI: 10.1038/ncomms1432. View

10.

Briand S, Mounts A, Chamberland M . Challenges of global surveillance during an influenza pandemic. Public Health. 2011; 125(5):247-56. PMC: 7111716. DOI: 10.1016/j.puhe.2010.12.007. View

11.

Sandbulte M, Gao J, Straight T, Eichelberger M . A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens. Influenza Other Respir Viruses. 2011; 3(5):233-40. PMC: 4941552. DOI: 10.1111/j.1750-2659.2009.00094.x. View

12.

Wood J, Major D, Heath A, Newman R, Hoschler K, Stephenson I . Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard. Vaccine. 2011; 30(2):210-7. DOI: 10.1016/j.vaccine.2011.11.019. View